Revvity, Inc.

NYSE:RVTY

Medical - Diagnostics & Research

Healthcare
$152.43 -3.36%

-$3.40 today

Market cap
$17.02B
Beta
1.11
P/E (TTM)
45.4
EPS (TTM)
$2.15
Dividend yield
0.29%
52W Low $81.22High $118.30

Volume 1.09M

Average 1.27M

RVTY Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Revvity, Inc.NYSE: RVTY

Net Receivables · Q2 FY2026 · quarter ended Jul 2026

Net receivables rises 7.3% from a year ago

Net receivables stood at $709.18M at the end of Q2 FY2026, up 7.3% from a year earlier and up 2.6% from the prior quarter. Over 3 fiscal years it compounded at +6.7% a year.

Context

  • Net receivables amounted to 5.9% of total assets at the end of Q2 FY2026, up 0.5 pp from a year earlier.
  • Net receivables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +7.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJul 2026
$709.18M+2.6% QoQ
Last fiscal yearDec 2025
$744.67M+17.8% YoY
Year agoJun 2025
$661.14M+7.3% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.3%——
1 year+17.8%——
3-year CAGR+6.7%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
744.67M USD
Year-over-year change
+17.8%
4-year CAGR
+1.3%

Net Receivables vs competitors

How RVTY compares with its peers on the latest reported figures

  • RVTY's Jul 2026 net receivables of $709.18M is the 7th highest of the 11 companies compared; the peer median is $721.62M.
  • Its year-over-year change of +7.3% is the 5th highest of 11, against a peer median of +6.0%.
  • Net receivables amounts to 5.9% of total assets for RVTY, versus a peer median of 8.2%.
RVTY Competitors Peer median
Net Receivables for RVTY and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TMOThermo Fisher Scientific Inc.Sep 2026$9.63B -8.6%+3.9%8.4%
DHRDanaher CorporationSep 2026$5.13B +36.5%-8.2%5.5%
WATWaters CorporationJul 2026$1.99B +172.2%+4.7%8.0%
AAgilent Technologies, Inc.Jul 2026$1.48B +6.9%+1.9%10.6%
MTDMettler-Toledo International Inc.Jun 2026$731.48M +7.3%+3.1%19.9%
CRLCharles River Laboratories International, Inc.Jun 2026$711.76M -7.3%-2.0%9.4%
RVTYRevvity, Inc.Jul 2026$709.18M +7.3%+6.7%5.9%
BIOBio-Rad Laboratories, Inc.Jun 2026$441.8M -6.0%-1.5%4.3%
QGENQiagen N.V.Jun 2026$399.05M +3.4%-2.5%6.8%
TECHBio-Techne CorporationSep 2026$209.8M +14.1%+0.3%8.0%
MLABMesa Laboratories, Inc.Mar 2026$44.1M +5.1%+1.2%10.3%
Peer median (excluding RVTY) $721.62M+6.0%+0.8%8.2%

Competitors are the stored peer set for RVTY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents603.32M454.36M913.16M1.16B919.87M
Short-term Investments00689.92M00
Net Receivables707.94M612.78M632.81M632.4M744.67M
Inventory425.89M405.46M428.06M367.59M379.5M
Other Current Assets703.63M1.82B337.14M186.23M195.71M
Total Current Assets2.44B3.29B3B2.35B2.24B
Property, Plant & Equipment (Net)649.57M671.3M664.74M649.93M644.69M
Goodwill6.63B6.48B6.53B6.46B6.61B
Intangible Assets3.82B3.38B3.02B2.64B2.35B
Long-term Investments110.94M144.62M0124.94M1.16M
Tax Assets00000
Other Non-current Assets1.35B166.44M342.97M163.45M322.32M
Total Non-current Assets12.56B10.84B10.56B10.04B9.93B
Total Assets15B14.13B13.56B12.39B12.17B
Account Payables324.81M272.83M204.12M167.46M185.46M
Short-term Debt4.24M470.93M721.87M242K588.83M
Tax Payables90.96M45.63M88.16M00
Deferred Revenue138.05M135.53M135.56M140.21M0
Other Current Liabilities257.79M324.85M43.28M44.18M556.95M
Total Current Liabilities1.21B1.54B1.45B653.1M1.33B
Long-term Debt4.98B3.92B3.18B3.15B2.78B
Deferred Tax Liabilities1.43B1.11B000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities91.7M0930.95M770.52M659.35M
Total Non-current Liabilities6.65B5.2B4.24B4.07B3.59B
Total Liabilities7.86B6.75B5.69B4.73B4.92B
Common Stock126.24M126.3M123.43M120.65M112.28M
Retained Earnings4.42B4.95B5.61B5.85B6.05B
Accumulated OCI(162.69M)(447.5M)(276.69M)(396.11M)(222.14M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity7.14B7.38B7.87B7.67B7.25B
Total Debt5.16B4.6B4.07B3.33B3.52B
Net Debt4.56B4.14B3.15B2.16B2.6B

Revvity, Inc.

NYSE:RVTY

Intrinsic Alpha fair value

Locked

Current Price

$152.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.